Healthcare
Diagnostics & Research
$26.13B
17.3K
Key insights and themes extracted from this filing
Net sales were $946.8 million for the three months ended June 30, 2024, compared to $982.1 million for the same period in 2023, a decrease of 4%. For the six months ended June 30, 2024, net sales were $1.87 billion, a decrease of 2% compared to $1.91 billion in 2023.
Gross profit as a percentage of net sales was 59.7% for Q2 2024 compared to 59.4% for Q2 2023. For the six months ended June 30, gross profit was 59.5% compared to 59.1% in the prior year.
Net earnings were $221.8 million for the three months ended June 30, 2024, compared to $213.9 million for the same period in 2023. For the six months ended June 30, net earnings were $399.3 million compared to $402.4 million in 2023.